Leukemia
Leukemia
Advertisement
Laura LitwinConferences | March 31, 2025
Researchers assessed the cost effectiveness of ibrutinib, acalabrutinib, and zanubrutinib in multiple treatment settings.
Read More
Cecilia BrownConferences | March 28, 2025
A study presented at the NCCN Annual Conference shed light on the perspectives of patients and healthcare professionals.
Laura LitwinConferences | March 28, 2025
Researchers investigated underlying drivers of HRQOL degradation in CLL, including muscle weakness and fatigue.
Josie Montegaard, NPLeukemia | March 14, 2025
Josie Montegaard, NP, discusses key guidelines, criteria, and the need for flexibility when initiating treatment for CLL.
Josie Montegaard, NPLeukemia | February 28, 2025
Josie Montegaard, NP, shares how the right treatment timing and approach can influence quality of life for patients with CLL.
Teresa Hagan Thomas, PhD, RNHematology & Blood Cancer | February 25, 2025
The clinically focused intervention invovled a symptom assessment questionnaire followed by symptom support.
Ellinor Goergen, MDConferences | December 19, 2024
The CLL12 trial included patients with treatment-naive, asymptomatic, early-stage chronic lymphocytic leukemia.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOMultiple Myeloma | October 15, 2024
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses her experiences and shares resources.
Bereket Abraha Molla, MDConferences | September 20, 2024
Researchers evaluated the renal status of more than 250 patients receiving TKIs in a chronic myeloid leukemia clinic.
Scott D. Goldfarb, PharmD, MSConferences | September 19, 2024
Researchers presented the results of the observational study at the 2024 SOHO Meeting.
Mamtha Balla, MD, MPH, FACP, FAPCRConferences | September 18, 2024
Research presented at the Annual Meeting of the Society of Hematologic Oncology provided insights on outcomes and risks.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOHematology & Blood Cancer | September 18, 2024
Hear about an NP's journey into hematologic oncology and how she has seen the treatment landscape evolve.
Cecilia BrownConferences | February 20, 2025
Nurses, nurse administrators, physician assistants, and oncologists/hematologists shared their insights with researchers.
Robert DillardHematology & Blood Cancer | September 4, 2024
Digital interventions that target physical and mental well-being are needed for adult long-term survivals of ALL.
Cecilia BrownHematology & Blood Cancer | September 2, 2024
Nurses may be able to play a role in aligning views between patients and hematologists on prognosis and goals of care.
Cecilia BrownLeukemia | July 31, 2024
DSP-5336 is an investigational small-molecule inhibitor of the menin and MLL protein interaction.
Cecilia BrownLeukemia | July 8, 2024
It is now “first and only” bispecific T-cell engager therapy approved for consolidation treatment regardless of MRD ...
Christophe Willekens, MDConferences | July 8, 2024
Hear expert insights on managing treatment for these patients and the key signs and symptoms to monitor.
Cecilia BrownConferences | May 7, 2024
There is a “lack of consistency” among patient-reported outcome measures used to evaluate CML treatments.
Cecilia BrownConferences | April 5, 2024
The analysis of 10 clinical trials and 1 prospective cohort study provides a "benchmark for future studies" of the treatment.
Advertisement
Advertisement